Invitrogen™ Human LRR™1 Synthetic Peptide
LRRTM1 Synthetic Peptide, PEP-1210, from Invitrogen.
- Gene ID (Enter)
- 347730
- Species
- Human
- Purification method
- Purified
- Accession number
- Q86UE6
- Common name
- Human LRRTM1
- Brand
- Invitrogen
LRRTM1 Synthetic Peptide, PEP-1210, from Invitrogen.
LRRTM1 Synthetic Peptide, PEP-1210, from Invitrogen.
The Leucine-rich repeat transmembrane neuronal proteins (LRRTMs) are differentially expressed in the nervous system and were recently found to instruct presynaptic and mediate postsynaptic glutamatergic differentiation, with LRRTM1 and LRRTM2 most potent at inducing presynaptic differentiation. Each LRRTM protein is a type I transmembrane containing ten extracellular leucine-rich repeats and a short intracellular tail and has a developmentally regulated pattern distinct from all others. LRRTM1 is a maternally suppressed gene that is associated paternally with handedness and schizophrenia.
Species: Human.
Storage: -20°C.
Concentration: 200 μg/mL.
Research only (RUO).
Packaging: 50 μg.
| General | |
|---|---|
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15275209 |
| Specifications | |
| Gene ID (Enter) | 347730 |
| Species | Human |
| Purification method | Purified |
| Accession number | Q86UE6 |
| Common name | Human LRRTM1 |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formula | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| For use with (application) | Blocking Assay, Control |
| Gene symbol(s) | LRRTM1 |
| Lyophilized | No |
| Product type | Peptide |
| Quantity | 50 μg |
| Regulatory status | RUO - research use only |
| Storage and shipping | |
| Content and storage | -20°C |
| Conservative | 0.02% sodium azide |
| Storage stamp | PBS |
| Manufacturer ref. | PEP-1210 |
|---|---|
| Country of origin | United States |
| HS customs code | 3824 99 92 00 |